Overview of This Research:
This study involved four major activities in estimating the current size of the cell isolation market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments’ market size.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the cell isolation market’s total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry have been identified through extensive secondary research.
# The revenues generated by leading players operating in the cell isolation market have been determined through primary and secondary research.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
COVID-19 Impact on Cell Isolation Market:
COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.
Currently, various organizations are supporting the use of stem cells or regenerative medicine for vaccine development.
The governing board of the California Institute for Regenerative Medicine (CIRM) approved USD 5 million in funding for peer-reviewed regenerative medicine and stem cell research that could quickly advance treatments for COVID-19.
Stem Cell Network (SCN) is providing up to USD 500,000 in funding to support rapid response research that uses a stem cell or regenerative medicine approach for addressing COVID-19.
Geographical Growth Scenario:
North America is the largest regional market for cell isolation market
The cell isolation market is segmented into four regions, namely, North America, Europe, Asia Pacific and Rest of the world. In 2019, North America accounted for the largest share of the cell isolation market. The large share of North America can be attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
Key Industry Players:
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US).
